Ineffectiveness of ipratropium bromide in acute bronchiolitis.
In a double blind randomised trial, we found no evidence that nebulised ipratropium bromide was of clinical benefit in acute bronchiolitis.
D000208:Acute Disease; D001286:Atropine Derivatives / Q000627:therapeutic use*; D001990:Bronchiolitis, Viral / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007223:Infant; D009241:Ipratropium / Q000627:therapeutic use*; D008297:Male; D011897:Random Allocation; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000188:drug therapy
D001286:Atropine Derivatives; D009241:Ipratropium